Emilia Zalewska and Andrzej Stelmachowski of Bird & Bird provide insights into two matters considered by the Unified Patent Court and a Polish court concerning the imminent infringement of patent ...

“A tailored strategy can help maximize the advantages of China’s administrative patent infringement procedure while minimizing uncertainties.” There are two distinct procedures available to ...

Voting technology company Smartmatic convinced a U.S. appeals court on Tuesday to uphold its win against a patent infringement lawsuit brought by rival Election Systems & Software. Deere & Co ...

The company has begun investigating its competitors for alleged patent infringement. Following initial investigations, the company said it believes it has valid and enforceable patents related to ...

Oct 15 (Reuters) - Voting technology company Smartmatic convinced a U.S. appeals court on Tuesday to uphold its win against a patent infringement lawsuit brought by rival Election Systems & Software.

The GSK team filed patents related to these inventions in 2010, laying the groundwork for modern mRNA vaccine development. The groundbreaking aspect of GSK’s invention lies in the flexibility ...

Should OpenAI engage in conduct that deviates from the pledge, for example by suing another company or an individual for patent infringement, what OpenAI has lost temporarily is credibility.” ...

SYK), alleging infringement of 9 patents related to Treace’s innovative Lapiplasty® 3D Bunion Correction® technologies and unfair competition. The suit was filed in the United States District ...

Northwestern is seeking damages for the alleged infringement but is not requesting injunctive relief, meaning it is not seeking to block the continued sale of the vaccines. In a statement to ...

Sales of both vaccines declined significantly last year from 2022. GSK also sued Pfizer for patent infringement over its RSV shot Abrysvo last year. The U.S. Food and Drug Administration approved ...

A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030. After a four-day bench ...